CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
EFLA400 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01479426
NCT01479426N/ACompleted
CompareCT.gov

Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Erectile Dysfunction

Chonbuk National University Hospital·interventional·Posted Nov 24, 2011·Updated Sep 23, 2019

In Brief

A clinical study evaluating EFLA400 and Placebo for Healthy Subjects(Only Men). Completed, enrolled 80 participants across 1 site.

Detailed Summary

Korea red ginseng has been used in maintaining vitality throughout the globally and metabolism and actions on neurologic, cardiovascular, and endocrinologic system are studied. KRG has been used in various ailment, and to prove its efficacy for erectile dysfunction an international study on contries other than Korean was performed. In the present study, subjects with borderline organic and psychogenic erectile dysfunction will be included. KRG will be give daily, and placebo will be give as control. Outcomes including libido, erection, sexual activity, and sexual satisfaction will be measured.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects(Only Men)
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 24, 2011
Enrollment StartDec 1, 2010
Primary CompletionDec 1, 2011
Study CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 14.6 years ago

Interventions

EFLA400dietary

EFLA400(960mg/day)for 12 weeks

Placebodietary

Placebo(960mg/day) for 12 weeks